Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1989-4-17
|
pubmed:abstractText |
Measurements of sodium-dependent [3H]imipramine binding to intact human platelets from 20 human volunteers were made and compared to desipramine-defined binding, a method commonly employed in population studies of platelet [3H]imipramine sites. The density (Bmax) of sodium-dependent [3H]imipramine sides in platelets was significantly lower (449 +/- 36 sites/platelet) and the affinity (Kd) significantly higher (1.15 +/- 0.12 nM) than those obtained when excess desipramine was used to define specific binding (Bmax 654 +/- 33 sites/platelet, p less than 0.001; Kd 1.52 +/- 0.11 nM, p less than 0.001). There was no significant correlation between the density (Bmax) of sodium-dependent and desipramine-defined binding in individual subjects, suggesting that a different proportion of sites are labeled under the two assay conditions. No age-dependent variation was found in either Kd or Bmax values of sodium-dependent or desipramine-defined [3H]imipramine binding. The results suggest determination of sodium-dependent [3H]imipramine binding to intact platelets may be a useful measure for the estimation of [3H]imipramine recognition sites relevant to the serotonin uptake in studies of patients with affective disorders.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Desipramine,
http://linkedlifedata.com/resource/pubmed/chemical/Imipramine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Drug,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Neurotransmitter,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium,
http://linkedlifedata.com/resource/pubmed/chemical/imipramine receptor
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0006-3223
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
576-84
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2537664-Adult,
pubmed-meshheading:2537664-Blood Platelets,
pubmed-meshheading:2537664-Carrier Proteins,
pubmed-meshheading:2537664-Desipramine,
pubmed-meshheading:2537664-Female,
pubmed-meshheading:2537664-Humans,
pubmed-meshheading:2537664-Imipramine,
pubmed-meshheading:2537664-Male,
pubmed-meshheading:2537664-Middle Aged,
pubmed-meshheading:2537664-Receptors, Drug,
pubmed-meshheading:2537664-Receptors, Neurotransmitter,
pubmed-meshheading:2537664-Sodium
|
pubmed:year |
1989
|
pubmed:articleTitle |
Differences between sodium-dependent and desipramine-defined [3H]imipramine binding in intact human platelets.
|
pubmed:affiliation |
Department of Pharmacology, School of Medicine, University of Ottawa, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|